Pharmaceutical manufacturers of Glibenclamide

TAPI stands as the primary global provider of active pharmaceutical ingredients (APIs). With the most extensive range of over 370 high-caliber API products in the industry, we cater to almost 1,000 clients across more than 100 nations. Operating as an independent division under Teva Pharmaceutical Industries, our legacy in the generic API sector spans over 80 years. Situated in close proximity to Tel Aviv, Israel, TAPI boasts a workforce of over 5,000 professionals spread across 19 facilities worldwide. Our cutting-edge manufacturing plants are situated in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, and several other locations.

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.

USV is a 60-year-old organization headquartered in Mumbai, generating approximately US$ 500 million in revenue, primarily from the Diabetic and Cardiac sectors. It is one of the top 15 companies in India, operating in over 60 countries and serving more than 100 satisfied customers with exports totaling around US$ 100 million. With 100+ product approvals globally and 30+ DMF submissions worldwide, USV provides value-added products in Oral Solids, Injectables (PFS, Vials), Ophthalmics, Biosimilars (Pegfilgrastim), and Peptides.

Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 employees, 4 cGMP plants and commercial offices in Italy, U.S.A. and China. We put our heart and soul into supporting our customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies. As a third-generation family-owned company, we have a long history of stability, commitment and financial solidity. We know how to deliver on creative innovation and we understand the critical importance of matching timelines, while operating in full respect of international regulations, Intellectual Property and third-party patents.

Cambrex stands as a prominent global contract development and manufacturing organization (CDMO) delivering comprehensive analytical and IND enabling services, along with drug substance development and manufacturing throughout the entire drug lifecycle. Boasting 40 years of expertise and a workforce of 2,000 professionals catering to international clients from North America and Europe, Cambrex is a reliable ally in both the branded and generic markets for API development and manufacturing. The company provides a variety of specialized drug substance technologies and capabilities.

Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past seven decades, we have been developing and manufacturing affordable medicines for patients around the world. Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life.

CCSB has developed more than 30 bulk pharmaceutical products including Anti-Anxiety agent, Antidiabetics, Laxatives, Antifungals, Antihistamines, Antiseptics, Antiulcerants, Cardiovascular drugs, Skeletal, Muscle relaxants, Hypolipaemics, Antineoplastic, Antihyperlipedemia and Immunosuppresant. In 1984, CCSB was the first pharmaceutical manufacturer in Taiwan inspected and approved by FDA for cGMP compliance. CCSB has filed DMF's for 19 products with the FDA.

Axyntis Group, established in 2007, is the foremost independent multi-location entity in the field of fine chemicals in France, generating an annual revenue of €90 million. Axyntis has evolved into a significant manufacturer of APIs in France through acquisitions and collaborations. It encompasses two sectors (colorants and fine chemicals) and emphasizes diversification and pioneering initiatives. The company operates three cGMP facilities in France, two of which are approved by the FDA. It offers CDMO services to partners for their API or advanced intermediate projects, from the initial development phase to the commercial stage, inclusive of preparative chromatography (Kyrapharm subsidiary). Additionally, it markets exclusive APIs.

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

Sri Krishna Pharmaceuticals Ltd (SKPL), established in 1974, started life as a pioneer in the bulk manufacture of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple first-line-of-defence APIs, PFIs and finished dosage drugs. Paracetamol is still very important to the company and the company remains one of the largest manufacturers in the world. The role of Indian bulk drug manufacturers in the global pharma supply chain has evolved greatly, with SKPL increasing its presence in the synthesis of bulk APIs, direct compression, intermediate and finished dosage products.

Zentiva manufactures cost-effective pharmaceuticals to serve patients across Europe and other regions. The company employs over 4,500 individuals and operates production facilities in various locations, including key sites in Prague, Bucharest, and Ankleshwar. Zentiva aims to become a leading provider of both branded and generic medications in Europe, catering to the diverse healthcare requirements of the population. The company advocates for the accessibility of high-quality affordable healthcare for all, emphasizing that it should be a fundamental right rather than a privilege. Zentiva collaborates closely with medical professionals to ensure improved availability of superior yet economical medicines and healthcare services.

Over the last 100 years, Celanese has evolved from a small experiment in a backyard shed in Switzerland to a global technology and specialty materials company with leading businesses in key geographic regions. The Dreyfus brothers had a vision for the company that included discovering market needs and finding ways to fulfill them. By honing their ability to diversify and adapt, the brothers were able to expand the company to one of the largest chemical manufacturers in the world. With a focus on safety, innovation, productivity, culture, performance and results, Celanese is positioned to achieve significant future growth and deliver exceptional results for all stakeholders. Our history below highlights the milestones that formed Celanese.

Elixir Pharma was established in September 2009 by a team of experienced techno-commercial professionals in Ahmadabad, Gujarat (India). The company aims to become a prominent provider of Fine Chemicals, Intermediates, APIs & Chemistry Services to Global Life Science Companies, facilitating the introduction of innovative products to markets in a cost-effective and efficient manner. With a proficient team of scientists & engineers, GLP compliant labs, and WHO GMP manufacturing plants in Ahmadabad, Elixir Pharma is well-positioned to deliver quality products and Intermediates promptly.